Selecky Christobel

DirectorImmunityBio, Inc. (IBRX) · full profile →Form 4 · filed Jan 21, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$438K
Net Open-Market Flow
-$438K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 20, 2026Option exercise(M)25K$2.98$75K25K
Jan 20, 2026Sell(S)25K$7.51$188K0
Jan 16, 2026Option exercise(M)50K$2.98$149K50K
Jan 16, 2026Sell(S)50K$5.00$250K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 20, 2026Option exercise(M)25K$093K
Jan 16, 2026Option exercise(M)50K$0118K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001849739-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly: